Daniel L. Baxter
Investor Relations Kontakt bei Global Developments, Inc.
Profil
Mr. Daniel L.
Baxter is Head-Investor Relations at Global Developments, Inc. He is on the Board of Directors at Global Developments, Inc. (Canada).
Mr. Baxter was previously employed as Chief Executive Officer by Infrastructure Developments Corp.
and Chief Executive & Financial Officer by Kinder Travel, Inc.
He received his undergraduate degree from the University of British Columbia.
Aktive Positionen von Daniel L. Baxter
| Unternehmen | Position | Beginn |
|---|---|---|
Global Developments, Inc.
 Global Developments, Inc. Financial ConglomeratesFinance Global Developments, Inc. engages in investment and portfolio management. The company is headquartered in Surrey, Canada. | Investor Relations Kontakt | - |
Ehemalige bekannte Positionen von Daniel L. Baxter
| Unternehmen | Position | Ende |
|---|---|---|
Genova Biotherapeutics, Inc.
 Genova Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Genova Biotherapeutics, Inc. is a biotechnological drug development company with a focus on identifying, evaluating and acquiring new promising drugs for treatment and prevention of oncological and infectious diseases in human beings. The company currently holds rights to pending patent applications for three medicines. Patent applications for each of the three drugs are Prostate cancer treatment & Breast cancer treatment. Prostate cancer treatment relates to the use of short polypeptides for treatment of cancers and more particular for the treatment of prostate cancer. Breast cancer treatment provides treatment for patients suffering from cancer and more preferably from breast cancer using new lipid derivatives such as tetanolic acid. The company was founded in December 6, 2005 and is headquartered in New York, NY. | Finanzdirektor/CFO | 02.09.2008 |
| INFRASTRUCTURE DEVELOPMENTS CORP. | Präsident | - |
| VEEMOST TECHNOLOGIES HOLDINGS, INC. | Direktor/Vorstandsmitglied | - |
Ausbildung von Daniel L. Baxter
| University of British Columbia | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| VEEMOST TECHNOLOGIES HOLDINGS, INC. | Communications |
| Private Unternehmen | 3 |
|---|---|
Genova Biotherapeutics, Inc.
Genova Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Genova Biotherapeutics, Inc. is a biotechnological drug development company with a focus on identifying, evaluating and acquiring new promising drugs for treatment and prevention of oncological and infectious diseases in human beings. The company currently holds rights to pending patent applications for three medicines. Patent applications for each of the three drugs are Prostate cancer treatment & Breast cancer treatment. Prostate cancer treatment relates to the use of short polypeptides for treatment of cancers and more particular for the treatment of prostate cancer. Breast cancer treatment provides treatment for patients suffering from cancer and more preferably from breast cancer using new lipid derivatives such as tetanolic acid. The company was founded in December 6, 2005 and is headquartered in New York, NY. | Health Technology |
Global Developments, Inc.
Global Developments, Inc. Financial ConglomeratesFinance Global Developments, Inc. engages in investment and portfolio management. The company is headquartered in Surrey, Canada. | Finance |
Infrastructure Developments Corp.
 Infrastructure Developments Corp. Engineering & ConstructionIndustrial Services Infrastructure Developments Corp. engages in engineering and construction services. It also offers project management services for construction projects. The company was founded on August 10, 2006 and is headquartered in Salt Lake City, UT. | Industrial Services |
